Not a member yet? Register here
Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia
Zanubrutinib as a new treatment option for patients with Waldenström macroglobulinaemia
FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma
Amsterdam scientists investigate why immunotherapy fails in Chronic Lymphocytic Leukaemia
New haematology reimbursement in Belgium: axicabtagene ciloleucel (Yescarta
) for ...
Rondaptivon pegol can be used as a treatment for severe and nonsevere haemophilia A
Index latest issue
The impact of drone transport on blood quality
BHS guidelines for the management of small lymphocytic lymphoma and chronic lymphocytic leukaemia, anno 2024
Straight to the heart
Highlights from the International Conference on Malignant Lymphoma (ICML)
Haematological highlights from ASCO 2023
New haematology reimbursements in Belgium
The Myeloma platform for online education on multiple myeloma
Wearable device for tracking temperature of paediatric blood cancer patients at home
Decitabine monotherapy: A safer alternative to chemotherapy for older patients with AML
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...
Cancer-associated thrombosis awareness survey (ECPC)
Canakinumab in children and young adults with sickle cell anaemia
Long-term remission rates after treatment with tisagenlecleucel in paediatric and young adult ...
Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients
New Danish app helps doctors in making better decisions for leukaemia patients